Vaginal Atrophy News and Research

RSS
EMA accepts Pfizer’s bazedoxifene/conjugated estrogens MAA for review

EMA accepts Pfizer’s bazedoxifene/conjugated estrogens MAA for review

Bayer receives FDA approval for lower dose formulation of ANGELIQ

Bayer receives FDA approval for lower dose formulation of ANGELIQ

Hygeia completes HYG-102 preclinical studies for vulvar and vaginal atrophy, and age-related skin fragility

Hygeia completes HYG-102 preclinical studies for vulvar and vaginal atrophy, and age-related skin fragility

IMS launches new Recommendations to manage postmenopausal vaginal atrophy

IMS launches new Recommendations to manage postmenopausal vaginal atrophy

Big Ow awareness campaign

Big Ow awareness campaign

Hormone therapy: An important treatment option for post-menopausal women

Hormone therapy: An important treatment option for post-menopausal women

Quatrx' second phase 3 study of ospemifene tablets provides positive results

Quatrx' second phase 3 study of ospemifene tablets provides positive results

New cream for vaginal dryness approved

New cream for vaginal dryness approved

Bionovo discovers new estrogen regulatory elements for breast cancer and osteoporosis drugs

Bionovo discovers new estrogen regulatory elements for breast cancer and osteoporosis drugs

No apparent increase in coronary heart disease for women who initiate hormone therapy

No apparent increase in coronary heart disease for women who initiate hormone therapy

Ospemifine may also help to prevent breast cancer

Ospemifine may also help to prevent breast cancer

Findings from WHI memory study may not directly apply to newly menopausal women

Findings from WHI memory study may not directly apply to newly menopausal women